Resources

Publications

09/17/2022
- Oncology
Purity Independent Subtyping of Tumor (PurIST): Real-World Data Validation of a Pancreatic Ductal Adenocarcinoma (PDAC) Gene Expression Classifier and Its Prognostic Implications
AACR Pancreatic Cancer Special Session 2022
09/16/2022
- Neuro/Psych
Pharmacogenomic Testing and Depressive Symptom Remission: A Systematic Review and Meta-Analysis of Prospective, Controlled Clinical Trials
Clinical Pharmacology & Therapeutics
09/09/2022
- Oncology
Safety, Tolerability and Efficacy of Agonist Anti-CD27 Antibody (Varlilumab) Administered in Combination With Anti PD-1 (Nivolumab) in Advanced Solid Tumors
Journal for ImmunoTherapy of Cancer
09/06/2022
- Oncology
Molecular Classification of Cancers of Unknown Primary Expands and Refines Treatment Options
ESMO 2022
09/06/2022
- Oncology
BRAF Mutations and Fusions in a Real-World Cohort of NSCLC Patients
ESMO 2022
09/06/2022
- Oncology
The Genomic Landscape of Small Cell Lung Cancer in Never Smoking Patients
ESMO 2022
08/03/2022
- Oncology
Discoidin Domain Receptor-Driven Gene Signatures as Markers of Patient Response to Anti–PD-L1 Immune Checkpoint Therapy
Journal of the National Cancer Institute
08/03/2022
- Oncology
Discoidin Domain Receptor-Driven Gene Signatures as Markers of Patient Response to Anti–PD-L1 Immune Checkpoint Therapy
JNCI: Journal of the National Cancer Institute
07/26/2022
- Oncology
Comparison of the Tumor Immune Microenvironment and Checkpoint Blockade Biomarkers Between Stage III and IV Non-small Cell Lung Cancer
Cancer Immunology, Immunotherapy, Tempus-authored
07/13/2022
- Oncology
Integration of Tumor Extrinsic and Intrinsic Features Associates With Immunotherapy Response in Non-small Cell Lung Cancer
Nature Communications, Tempus-authored

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40